Germ-killing copper surfaces in hospitals could save thousands of lives
September 8, 2012 in Diseases, Conditions, Syndromes
An antimicrobial copper rail installed in a hospital. Credit: University of Arizona
When Adam Estelle graduated from the University of Arizona's materials science and engineering program four years ago, he had no idea he would be involved in saving thousands of lives.
Like most graduates, he was just hoping to find a job—preferably in Tucson, Ariz., because he wasn't interested in big-city life. What happened next was a job offer from the Copper Development Association in New York City.
Fast-forward four years, and Estelle says, "I love New York more and more every day. And the most rewarding thing for me is the ability to work on a project centered on a technology that will save lives. That's immensely rewarding."
The technology is based on copper alloys that kill bacteria, fungi and viruses. The metals can be fashioned into everything from IV poles to sinks to bed rails—just about anything that is frequently touched in hospitals.
While these surfaces might look benign, they're covered with organisms that contribute to hospital-acquired infections, the fourth leading cause of death in the United States, killing more people than AIDS and breast cancer combined. That's 2 million infections annually, and 100,000 deaths—one infection for every 20 people admitted to hospitals.
While disease-causing organisms can lurk on stainless steel surfaces for two weeks, according to a recent UA research study, 99.9 percent die within two hours on surfaces that contain at least 60 percent copper, Estelle says.
Estelle has been working with four other engineers at the Copper Development Association, a not-for-profit trade group, to develop a market for copper alloys in the health care industry. They also have been helping manufacturers gear up for producing copper alloy products.
Part of that effort has involved gaining EPA certification for the antimicrobial effects of copper so manufacturers can advertise the health benefits of these products.
The second part, which has been Estelle's major focus for the past two years, was to retrofit the Ronald McDonald House in Charleston, S.C., with copper alloy stair railings, door hardware, sinks, faucets, counter tops, kitchen tables, chair arms, and other surfaces that are frequently touched by patients, visitors and staff.
This has been a win-win for everyone, Estelle explained, creating a safer environment for families and children, while at the same time helping the first wave of manufacturers tool up and commercialize lines of copper products that can now be marketed to hospitals.
"One of our first commercial products is a beautiful seamless counter top and sink bowl manufactured by Elkay Commercial Products," Estelle said. "We installed about forty of these in the Ronald McDonald House." Elkay is among ten manufacturers now marketing antimicrobial copper alloy products to the health care industry.
Surfaces at the Ronald McDonald House were swabbed and tested for bacteria for ten weeks before the new copper alloy products were installed. "Follow-up tests on the items converted to copper showed they carried 94 percent fewer bacteria," Estelle said. "We are now trying to recreate the Charleston project at other Ronald McDonald Houses around the world to create a safer living and working environment for the children, families and staff."
Now, with the Ronald McDonald House pilot project completed and EPA approval secured, the next step is to convince hospitals to replace traditional surfaces that are not worn out with copper alloy ones. New policies from the Centers for Medicare and Medicaid Services that go into effect next year should help spur this changeover. Treatment for hospital-acquired infections costs between $35 billion and $45 billion each year in the U.S., and Medicare and Medicaid will no long reimburse hospitals for that treatment if the infections are judged to have been preventable and a hospital mistake.
But even without the new rules, the changeover makes economic sense, Estelle explained. Under today's reimbursement system, individual hospitals spend $5 million on average each year to treat infections. "Even on the low end, it's $30,000 per infection," he said. Clinical trials at three hospitals funded by the U.S. Department of Defense have recently proved that copper surfaces can reduce infections in the intensive care unit by more than 50 percent.
Using published estimates, about 500,000 Americans will contract an infection this year in the ICU. This will cost our hospitals an additional $3.5 billion in treatment, and about 40,000 people will not survive the ordeal. The clinical trial results suggest that installing copper surfaces could cut these figures in half.
"By implementing these surfaces, hospitals can see real, continuous savings year after year," Estelle said. "This is a passive way to prevent infection that doesn't depend on human behavior, such as hand-washing or hydrogen peroxide vapor machines. There is no need for maintenance beyond the normal surface cleaning procedures that are already in place."
Working for a small company that is on the leading edge of developing a new market has been rewarding and challenging, Estelle said. While his engineering courses didn't teach all the skills he's needed, the problem-solving techniques he learned at UA certainly have helped.
"I get involved in everything from supply chain development and marketing to clinical trials, regulatory approvals, Congressional advocacy, and more," Estelle said. "This is really a multidisciplinary job, and a lot of it is business-oriented. There's a lot of on-the-job networking, and interfacing with different professionals."
"But the most rewarding thing for me is the ability to work on a project that centers on technology that will save lives," he said. "I'm a pretty lucky guy."
Provided by
University of Arizona
-
Copper surfaces could reduce hospital acquired infections
Jul 23, 2012 |
not rated yet |
0
-
Copper reduces infection risk by more than 40 percent
Jul 01, 2011 |
not rated yet |
0
-
Study proves new technology kills bacteria
Oct 20, 2011 |
not rated yet |
0
-
MRSA eliminated by copper in live global broadcast
Apr 04, 2011 |
not rated yet |
0
-
UCLA study to determine if copper surfaces can reduce hospital-acquired infections
Jul 09, 2012 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
Swine flu pandemic of 2009 more deadly for younger adults, study finds
As the world prepares for what may be the next pandemic strain of influenza virus, in the H7N9 bird flu, a new UC Irvine study reveals that the 2009 H1N1 swine flu pandemic was deadliest for people under the age of 65, while ...
Diseases, Conditions, Syndromes
12 hours ago |
not rated yet |
0
Polio cases found in Kenya and Somalia, WHO says
The World Health Organization says the Horn of Africa is experiencing an outbreak of polio with cases confirmed in Kenya and Somalia.
Diseases, Conditions, Syndromes
13 hours ago |
not rated yet |
0
SARS-like virus claims new life in Saudi
A man who had contracted the coronavirus has died in Saudi Arabia, raising the death toll in the kingdom from the SARS-like virus to 17, the health ministry announced on its website on Wednesday.
Diseases, Conditions, Syndromes
13 hours ago |
not rated yet |
0
Novel approach for influenza vaccination shows promise in early animal testing
A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine ...
Diseases, Conditions, Syndromes
14 hours ago |
not rated yet |
0
|
Mild hypothyroidism raises mortality risk among heart failure patients
Patients with underlying heart failure are more likely to experience adverse outcomes from mild hypothyroidism, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & ...
Diseases, Conditions, Syndromes
16 hours ago |
not rated yet |
0
Slowing the aging process—only with antibiotics
Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.
Researchers complete largest genetic sequencing study of human disease
Researchers from Queen Mary, University of London have led the largest sequencing study of human disease to date, investigating the genetic basis of six autoimmune diseases.
Brain can be trained in compassion, study shows
Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.
Having both migraines, depression may mean smaller brain
(HealthDay)—Migraines and depression can each cause a great deal of suffering, but new research indicates the combination of the two may be linked to something else entirely—a smaller brain.
Rate of bicycle-related fatalities significantly lower in states with helmet laws
Existing research shows that bicyclists who wear helmets have an 88 percent lower risk of brain injury, but researchers at Boston Children's Hospital found that simply having bicycle helmet laws in place showed a 20 percent ...
Enzyme-activating antibodies revealed as marker for most severe form of rheumatoid arthritis
In a series of lab experiments designed to unravel the workings of a key enzyme widely considered a possible trigger of rheumatoid arthritis, researchers at Johns Hopkins have found that in the most severe ...